Advanced testicular cancer is a model for a chemotherapeutically curable solid neoplasm. The current standard of therapy is cisplatin-based chemotherapy administered over three to four courses depending on the extent of the disease. The long-term sequelae are few. More recent studies have started to define the minimum therapy necessary for good-risk patients. Ongoing studies are evaluating more aggressive innovative therapies for high- risk patients.
|Original language||English (US)|
|Number of pages||15|
|Journal||Hematology/Oncology Clinics of North America|
|State||Published - Jan 1 1991|
ASJC Scopus subject areas